Stenting and Catheterization
The website you have requested may contain information on products or uses of such products that are not approved in your country.
For specific product and country information please contact Medinol.
Implanting the seeds of medical innovation
Medinol Group is a MedTech Hub focused on the development of innovative medical technologies of implantable medical devices.
Structural Heart
Implantable Microsensors
INNOVATION
Leveraging superior in-house R&D, clinical and regulatory capabilities, robust patent portfolio and legacy of innovation the Medinol Group continuously redefines medical device development with medical innovations and technological advancements.
Clinical Program
Partners
NEWS
May 5, 2020
Medinol Completes Enrollment of EluNIR-HBR Study
Apr 4, 2020
Medinol Enrolls a First-in-Human Study of ChampioNIR® SFA Stent System
Jan 1, 2018
Medinol Announce First U.S. Commercial Implants of Innovative EluNIR™ ...
Nov 11, 2017
Cordis Announce FDA Approval of the Innovative EluNIR™ Drug-Eluting Stent ...
Oct 10, 2017
Medinol Ltd. Receives CE Mark for the EluNIR™ Ridaforolimus-Eluting ...
Dec 12, 2016
Medinol announces excellent clinical results for EluNIR, a novel Drug ...
Nov 11, 2016
Medinol Receives Approval from The Japanese PMDA to Begin Clinical Study on ...
Oct 10, 2016